Montelukast mood symptoms — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Arrange prompt prescriber review for possible montelukast adverse effects
This scenario assesses Montelukast mood symptoms in a UK pharmacy practice context. Montelukast is associated with neuropsychiatric reactions and new mood or sleep symptoms require review. The best answer is Arrange prompt prescriber review for possible montelukast adverse effects because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: MHRA Drug Safety Update; BNF